Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-04

FDA Approved: ENTACAPONE — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals Limited's original application for Entacapone. Entacapone is a COMT inhibitor used as an adjunct to levodopa in Parkinson's…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entacapone (Entacapone)

Snippet

ORIG AP for ENTACAPONE (ENTACAPONE)